Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-C motif chemokine 2 (CCL2), also known as monocyte chemoattractant protein-1 (MCP-1) and small inducible cytokine A2, is a key member of the CC chemokine family involved in immune cell recruitment and inflammatory responses. It signals primarily through binding to its receptor CCR2, inducing strong chemotactic responses. Elevated levels of CCL2 are implicated in chronic inflammatory conditions and cancer progression, making it a potential therapeutic target.
Inhibition of CCL2 signaling prevents immune cell recruitment and reduces inflammation, angiogenesis, and tumor progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C motif chemokine 2 (CCL2).